Top

Archives of Osteoporosis

Published in:

01-12-2021 | Osteoporosis | Review Article

The current situation in the approach to osteoporosis in older adults in Turkey: areas in need of improvement with a model for other populations

Authors: Gulistan Bahat, Nezahat Muge Catikkas, Dilek Gogas Yavuz, Pinar Borman, Rengin Guzel, Jean Yves Reginster

Published in: Archives of Osteoporosis | Issue 1/2021

Abstract

Purpose

The total number of older adults in Turkey is striking, amounting to around 8 million, and this translates into considerably higher numbers of cases of osteoporosis (OP) and fractures in older adults. In this article, we outlined the current situation of OP in older adults in Turkey and investigated the differences between Turkey and a representative developed European country (Belgium), in terms of the screening, diagnosis, and treatment of OP. Our intention in this regard was to identify areas in need of improvement and subsequently to make a clear call for action to address these issues.

Methods

Herein, considering the steps related to the OP approach, we made a complete review of the studies conducted in Turkey and compared with the literature recommendations.

Results

There is a need for a national osteoporotic fracture registry; measures should be taken to improve the screening and treatment of OP in older males, such as educational activities; technicians involved in dual-energy X-ray absorptiometry (DXA) scanning should undergo routine periodic training; all DXA centers should identify center-specific least significant change values; all older adults should be considered for routine lateral dorsolumbar X-ray imaging for the screening of vertebral fractures while ordering DXA scans; the inclusion of vertebral fracture assessment (VFA) software in DXA assessments should be considered; screening using a fracture risk assessment tool (FRAX) algorithm that is specific to Turkey should be integrated; the fortification of foods with vitamin D is required; the high fracture risk by country-specific FRAX algorithm and the presence of falls/high fall risk should be integrated in reimbursement terms; and finally, more “fracture liaison services” should be established.

Conclusion

We suggest that the practical consideration of our suggestions will provide considerable support to the efforts for combating with the adverse consequences of OP in society. This approach can be subsequently modeled for other populations to improve the management of OP globally.

IOF. Access date September 22, 2021. https://www.osteoporosis.foundation/health-professionals/fragilityfractures/epidemiology

Ensrud KE (2013) Epidemiology of fracture risk with advancing age. J Gerontol A Biol Sci Med Sci 68(10):1236–1242. https://doi.org/10.1093/gerona/glt092CrossRefPubMed

Tuzun S, Eskiyurt N, Akarirmak U, Saridogan M, Senocak M, Johansson H, Kanis JA, Turkish Osteoporosis Society (2012) Incidence of hip fracture and prevalence of osteoporosis in Turkey: the FRACTURK study. Osteoporos Int. 23(3):949–55. https://doi.org/10.1007/s00198-011-1655-5CrossRefPubMed

Cauley JA, Thompson DE, Ensrud KC, Scott JC, Black D (2000) Risk of mortality following clinical fractures. Osteoporos Int 11(7):556–561. https://doi.org/10.1007/s001980070075CrossRefPubMed

Rizkallah M, Bachour F, Khoury ME, Sebaaly A, Finianos B, Hage RE, Maalouf G (2020) Comparison of morbidity and mortality of hip and vertebral fragility fractures: which one has the highest burden? Osteoporos Sarcopenia. 6(3):146–150. https://doi.org/10.1016/j.afos.2020.07.002CrossRefPubMedPubMedCentral

Gurger M (2019) Factors impacting 1-year mortality after hip fractures in elderly patients: a retrospective clinical study. Niger J Clin Pract 22(5):648–651. https://doi.org/10.4103/njcp.njcp_327_18CrossRefPubMed

Türkiye Endokrinoloji ve Metabolizma Derneği Osteoporoz ve Metabolik Kemik Hastalıkları Tanı ve Tedavi Kılavuzu. Bayt Bilimsel Araştırmalar Basın Yayın ve Tanıtım Ltd. Sti. Baskı Tarihi: Kasım 2020. ISBN: 987-605-4011-41-4

Beaudart C, Biver E, Bruyère O, Cooper C, Al-Daghri N, Reginster JY, Rizzoli R (2018) Quality of life assessment in musculo-skeletal health. Aging Clin Exp Res 30(5):413–418. https://doi.org/10.1007/s40520-017-0794-8CrossRefPubMed

Kirazlı Y, Atamaz Çalış F, El Ö, Kutsal YG, Peker Ö, Sindel D, Tuzun Ş, Gogas Yavuz D, Durmaz B, Akarirmak Ü, Bodur H, Hamuryudan V, Inceboz U, Öncel S (2020) Updated approach for the management of osteoporosis in Turkey: a consensus report. Arch Osteoporos 15(1):137. https://doi.org/10.1007/s11657-020-00799-0CrossRefPubMedPubMedCentral

10.

Aziziyeh R, Amin M, Habib M, Garcia Perlaza J, Szafranski K, McTavish RK, Disher T, Lüdke A, Cameron C (2019) The burden of osteoporosis in four Latin American countries: Brazil, Mexico, Colombia, and Argentina. J Med Econ 22(7):638–644. https://doi.org/10.1080/13696998.2019.1590843CrossRefPubMed

11.

Berry SD, Kiel DP, Colón-Emeric C (2019) Hip fractures in older adults in 2019. JAMA 321(22):2233–2234CrossRef

12.

Kanis JA, Odén A, McCloskey EV, Johansson H, Wahl DA, Cooper C, IOF Working Group on Epidemiology and Quality of Life (2012) A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int 23(9):2239–56. https://doi.org/10.1007/s00198-012-1964-3CrossRefPubMedPubMedCentral

13.

Kutsal YG, Atalay A, Arslan S, Başaran A, Cantürk F, Cindaş A, Eryavuz M, Irdesel J, Karadavut KI, Kirazli Y, Sindel D, Senel K, Güler-Uysal F, Yildirim K (2005) Awareness of osteoporotic patients. Osteoporos Int 16(2):128–133. https://doi.org/10.1007/s00198-004-1678-2CrossRefPubMed

14.

Keskin Y, Cekin MD, Gunduz H, Luleci NE, Giray E, Sur H, Akyuz G (2014) The prevalence of osteoporosis in the Thrace region of Turkey: a community-based study. Turk J Phys Med Rehab 60(4):335–340CrossRef

15.

Kucukler FK, Simsek Y, Turk AÇ, Arduc A, Guler S (2017) Osteoporosis and silent vertebral fractures in nursing home resident elderly men in Turkey. J Clin Densitom 20(2):188–195. https://doi.org/10.1016/j.jocd.2015.05.064CrossRefPubMed

16.

Kilci O, Un C, Sacan O, Gamli M, Baskan S, Baydar M, Ozkurt B (2016) Postoperative mortality after hip fracture surgery: a 3 years follow up. PLoS ONE 11(10):e0162097. https://doi.org/10.1371/journal.pone.0162097CrossRefPubMedPubMedCentral

17.

Tanriover MD, Oz SG, Tanriover A, Kilicarslan A, Turkmen E, Guven GS, Saracbasi O, Tokgozoglu M, Sozen T (2010) Hip fractures in a developing country: osteoporosis frequency, predisposing factors and treatment costs. Arch Gerontol Geriatr 50(3):e13-8. https://doi.org/10.1016/j.archger.2009.04.010CrossRefPubMed

18.

Cobden A, Cobden SB, Camurcu Y, Ucpunar H, Duman S, Sofu H (2019) Effects of postoperative osteoporosis treatment on subsequent fracture and the 5-year survival rates after hemiarthroplasty for hip fracture. Arch Osteoporos 14(1):100. https://doi.org/10.1007/s11657-019-0657-3CrossRefPubMed

19.

Aziziyeh R, Garcia Perlaza J, Saleem N, Kirazlı Y, Akalın E, McTavish RK, Duperrouzel C, Cameron C (2020) The burden of osteoporosis in Turkey: a scorecard and economic model. Arch Osteoporos 15(1):128. https://doi.org/10.1007/s11657-020-00801-9CrossRefPubMed

20.

Kendler DL, Bauer DC, Davison KS, Dian L, Hanley DA, Harris ST, McClung MR, Miller PD, Schousboe JT, Yuen CK, Lewiecki EM (2016) Vertebral fractures: clinical importance and management. Am J Med 129(2):221.e1–10. https://doi.org/10.1016/j.amjmed.2015.09.020CrossRef

21.

Shuhart CR, Yeap SS, Anderson PA, Jankowski LG, Lewiecki EM, Morse LR, Rosen HN, Weber DR, Zemel BS, Shepherd JA (2019) Executive summary of the 2019 ISCD position development conference on monitoring treatment, DXA cross-calibration and least significant change, spinal cord injury, peri-prosthetic and orthopedic bone health, transgender medicine, and pediatrics. J Clin Densitom 22(4):453–471. https://doi.org/10.1016/j.jocd.2019.07.001CrossRefPubMed

22.

Karahan AY, Kaya B, Kuran B, Altındag O, Yildirim P, Dogan SC, Basaran A, Salbas E, Altınbilek T, Guler T, Tolu S, Hasbek Z, Ordahan B, Kaydok E, Yucel U, Yesilyurt S, Polat AD, Cubukcu M, Nas O, Sarp U, Yasar O, Kucuksarac S, Turkoglu G, Karadag A, Bagcaci S, Erol K, Guler E, Tuna S, Yildirim A, Karpuz S (2016) Common mistakes in the dual-energy X-ray absorptiometry (DXA) in Turkey. A retrospective descriptive multicenter study. Acta Medica (Hradec Kralove) 59(4):117–123. https://doi.org/10.14712/18059694.2017.38CrossRef

23.

Tuna F, Yavuz S, Demirbağ Kabayel DD, Sarıkaya A (2017) Effects of clinical reanalysis in dual energy X-ray absorptiometry reports. Turk J Phys Med Rehabil 63(3):201–206. https://doi.org/10.5606/tftrd.2017.595CrossRefPubMedPubMedCentral

24.

Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R, National Osteoporosis Foundation (2014) Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int 25(10):2359–81. https://doi.org/10.1007/s00198-014-2794-2CrossRefPubMedPubMedCentral

25.

Lenchik L, Rogers LF, Delmas PD, Genant HK (2004) Diagnosis of osteoporotic vertebral fractures: importance of recognition and description by radiologists. AJR Am J Roentgenol 183(4):949–958. https://doi.org/10.2214/ajr.183.4.1830949CrossRefPubMed

26.

Yang J, Cosman F, Stone PW, Li M, Nieves JW (2020) Vertebral fracture assessment (VFA) for osteoporosis screening in US postmenopausal women: is it cost-effective? Osteoporos Int 31(12):2321–2335. https://doi.org/10.1007/s00198-020-05588-6CrossRefPubMed

27.

Kanis JA, McCloskey EV, Johansson H, Strom O, Borgstrom F, Oden A, National Osteoporosis Guideline Group (2008) Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK. Osteoporos Int 19(10):1395–1408. https://doi.org/10.1007/s00198-008-0712-1. Erratum in: Osteoporos Int. 2009;20(3):499–502

28.

Kanis JA, Johansson H, Harvey NC, Gudnason V, Sigurdsson G, Siggeirsdottir K, Lorentzon M, Liu E, Vandenput L, McCloskey EV (2020) Adjusting conventional FRAX estimates of fracture probability according to the recency of sentinel fractures. Osteoporos Int 31(10):1817–1828. https://doi.org/10.1007/s00198-020-05517-7CrossRefPubMedPubMedCentral

29.

Alpdemir M, Alpdemir MF (2019) Vitamin D deficiency status in Turkey: a meta-analysis. Int J Med Biochem 2(3):118–131. https://doi.org/10.14744/ijmb.2019.04127CrossRef

30.

Holick MF (2017) The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord 18(2):153–165. https://doi.org/10.1007/s11154-017-9424-1CrossRefPubMed

31.

Russo CR (2009) The effects of exercise on bone. Basic concepts and implications for the prevention of fractures. Clin Cases Miner Bone Metab 6(3):223–8PubMed

32.

Wallace JI (2017) Malnutrition and enteral/parenteral alimentation, Hazzard’s Geriatric Medicine and Gerontology. Chapter 35, 7th edn. The McGraw-Hill Companies, New York, p 737

33.

Bahat G, Tufan F, Bahat Z, Aydin Y, Tufan A, Akpinar TS, Erten N, Karan MA (2013) Assessments of functional status, comorbidities, polypharmacy, nutritional status and sarcopenia in Turkish community-dwelling male elderly. Aging Male 16(2):67–72. https://doi.org/10.3109/13685538.2013.771329CrossRefPubMed

34.

Bahat G, Tufan A, Aydin Y, Tufan F, Bahat Z, Akpinar TS, Soyluk O, Erten N, Karan MA (2015) The relationship of body mass index and the functional status of community-dwelling female older people admitting to a geriatric outpatient clinic. Aging Clin Exp Res 27(3):303–308. https://doi.org/10.1007/s40520-014-0291-2CrossRefPubMed

35.

Saka B, Ozkaya H, Karisik E, Akin S, Akpinar TS, Tufan F, Bahat G, Dogan H, Horasan Z, Cesur K, Erten N, Karan MA (2016) Malnutrition and sarcopenia are associated with increased mortality rate in nursing home residents: a prospective study. European Geriatric Medicine 7(3):232–238CrossRef

36.

Bahat G, Kilic C, Altinkaynak M, Akif KM (2020) Comparison of standard versus population-specific handgrip strength cut-off points in the detection of probable sarcopenia after launch of EWGSOP2. Aging Male 23(5):1564–1569. https://doi.org/10.1080/13685538.2020.1870038CrossRefPubMed

37.

Bahat G, Kilic C, Ozkok S, Ozturk S, Karan MA (2021) Associations of sarcopenic obesity versus sarcopenia alone with functionality. Clin Nutr 40(5):2851–2859. https://doi.org/10.1016/j.clnu.2021.04.002CrossRefPubMed

38.

Halil M, Ulger Z, Varlı M, Döventaş A, Oztürk GB, Kuyumcu ME, Yavuz BB, Yesil Y, Tufan F, Cankurtaran M, Saka B, Sahin S, Curgunlu A, Tekin N, Akçiçek F, Karan MA, Atlı T, Beger T, Erdinçler DS, Arıoğul S (2014) Sarcopenia assessment project in the nursing homes in Turkey. Eur J Clin Nutr 68(6):690–694. https://doi.org/10.1038/ejcn.2014.15CrossRefPubMed

39.

Yilmaz O, Bahat G, Kucukdagli, Ozalp H, Cakmakci C, Karan MA (2018) Poliklinikte ayaktan başvuran yaşlıların beslenme içeriği yeterli mi? 11. Akademik Geriatri Kongresi. 19–23 Nisan. Syf 131–132

40.

Volkert D, Beck AM, Cederholm T, Cruz-Jentoft A, Goisser S, Hooper L, Kiesswetter E, Maggio M, Raynaud-Simon A, Sieber CC, Sobotka L, van Asselt D, Wirth R, Bischoff SC (2019) ESPEN guideline on clinical nutrition and hydration in geriatrics. Clin Nutr 38(1):10–47. https://doi.org/10.1016/j.clnu.2018.05.024CrossRefPubMed

41.

Shah M (2017) Role of nutrition inmusculoskeletal health. In: Nonpharmacological management of osteoporosis. Springer, pp 53–59. https://doi.org/10.1007/978-3-319-54016-0_5

42.

Matsumoto H, Tanimura C, Kushida D, Osaka H, Kawabata Y, Hagino H (2020) FRAX score and recent fall history predict the incidence for sarcopenia in community-dwelling older adults: a prospective cohort study. Osteoporos Int 31(10):1985–1994. https://doi.org/10.1007/s00198-020-05447-4CrossRefPubMed

43.

Harvey NC, Odén A, Orwoll E, Lapidus J, Kwok T, Karlsson MK et al (2018) Falls predict fractures independently of FRAX probability: a Meta-Analysis of the Osteoporotic Fractures in Men (MrOS) study. J Bone Miner Res. 33(3):510–516. https://doi.org/10.1002/jbmr.3331CrossRefPubMed

44.

Bahat Öztürk G, Kılıç C, Bozkurt ME, Karan MA (2021) Prevalence and associates of fear of falling among community-dwelling older adults. J Nutr Health Aging 25(4):433–439. https://doi.org/10.1007/s12603-020-1535-9CrossRefPubMed

45.

Phelan EA, Mahoney JE, Voit JC, Stevens JA (2015) Assessment and management of fall risk in primary care settings. Med Clin North Am 99(2):281–293. https://doi.org/10.1016/j.mcna.2014.11.004CrossRefPubMedPubMedCentral

46.

Cuevas-Trisan R (2019) Balance problems and fall risks in older adults. Clin Geriatr Med 35(2):173–183. https://doi.org/10.1016/j.cger.2019.01.008CrossRefPubMed

47.

Thomas E, Battaglia G, Patti A, Brusa J, Leonardi V, Palma A et al (2019) Physical activity programs for balance and fall prevention in elderly: a systematic review. Medicine (Baltimore) 98(27):e16218. https://doi.org/10.1097/MD.0000000000016218CrossRef

48.

Erhan B, Ataker Y (2020) Rehabilitation of patients with osteoporotic fractures. J Clin Densitom 23(4):534–538. https://doi.org/10.1016/j.jocd.2020.06.006CrossRefPubMed

49.

Carter ND, Khan KM, McKay HA, Petit MA, Waterman C, Heinonen A, Janssen PA, Donaldson MG, Mallinson A, Riddell L, Kruse K, Prior JC, Flicker L (2002) Community-based exercise program reduces risk factors for falls in 65- to 75-year-old women with osteoporosis: randomized controlled trial. CMAJ 167(9):997–1004. Erratum in: CMAJ. 2003;168(2):152

50.

Çergel Y, Topuz O, Alkan H, Sarsan A, Sabir AN (2019) The effects of short-term back extensor strength training in postmenopausal osteoporotic women with vertebral fractures: comparison of supervised and home exercise program. Arch Osteoporos 14(1):82. https://doi.org/10.1007/s11657-019-0632-zCrossRefPubMed

51.

Murata K, Watanabe G, Kawaguchi S, Kanaya K, Horigome K, Yajima H, Morita T, Yamashita T (2012) Union rates and prognostic variables of osteoporotic vertebral fractures treated with a rigid external support. J Neurosurg Spine 17(5):469–475. https://doi.org/10.3171/2012.7.SPINE122CrossRefPubMed

52.

Valentin GH, Pedersen LN, Maribo T (2014) Wearing an active spinal orthosis improves back extensor strength in women with osteoporotic vertebral fractures. Prosthet Orthot Int 38(3):232–238. https://doi.org/10.1177/0309364613497393CrossRefPubMed

53.

Kutsal YG (2014) Yaşlıda osteoporoz. Kutsal YG, İrdesel J, Borman P, Ordu Gökkaya K (eds). Geriatrik Romatoloji. Öncü kitabevi s:351–366

54.

Bahat G, Ilhan B, Erdogan T, Halil M, Savas S, Ulger Z, Akyuz F, Bilge AK, Cakir S, Demirkan K, Erelel M, Guler K, Hanagasi H, Izgi B, Kadioglu A, Karan A, Kulaksizoglu IB, Mert A, Ozturk S, Satman I, Sever MS, Tukek T, Uresin Y, Yalcin O, Yesilot N, Oren MM, Karan MA (2020) Turkish inappropriate medication use in older adults (TIME) criteria to improve prescribing in older adults: TIME-to-STOP/TIME-to-START. Eur Geriatr Med 11(3):491–498. https://doi.org/10.1007/s41999-020-00297-zCrossRefPubMedPubMedCentral

55.

Cornelissen D, de Kunder S, Si L, Reginster JY, Evers S, Boonen A, Hiligsmann M, European Society for Clinical and Economic Aspect of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) (2020) Interventions to improve adherence to anti-osteoporosis medications: an updated systematic review. Osteoporos Int 31(9):1645–1669. https://doi.org/10.1007/s00198-020-05378-0CrossRefPubMedPubMedCentral

56.

Itkonen ST, Erkkola M, Lamberg-Allardt CJE (2018) Vitamin D fortification of fluid milk products and their contribution to vitamin D intake and vitamin D status in observational studies-a review. Nutrients 10(8):1054. https://doi.org/10.3390/nu10081054CrossRefPubMedCentral

57.

Atar MÖ (2018) Yaşlılarda osteoporoz ve osteomalazi. Sonel Tur B (ed). Yaşlılar için fiziksel Rehabilitasyon. Yaşlılığa çok yönlü bakış. Hedef Kitabevi. Ankara, s:84–93

58.

Vandenbroucke A, Luyten FP, Flamaing J, Gielen E (2017) Pharmacological treatment of osteoporosis in the oldest old. Clin Interv Aging 6(12):1065–1077. https://doi.org/10.2147/CIA.S131023CrossRef

59.

Institute of Medicine. Report at a glance. Report brief: dietary reference intakes for calcium and vitamin D, released 11/30/2010. http://www.iom.edu/Reports/2010/Dietary-Reference-Intakes-forCalcium-and-Vitamin-D/Report-Brief.aspx. Accessed on Dec 01, 2010

60.

Bischoff-Ferrari HA, Dawson-Hughes B, Orav EJ, Staehelin HB, Meyer OW, Theiler R, Dick W, Willett WC, Egli A (2016) Monthly high-dose vitamin D treatment for the prevention of functional decline: a randomized clinical trial. JAMA Intern Med 176(2):175–183. https://doi.org/10.1001/jamainternmed.2015.7148CrossRefPubMed

61.

Rizzoli R (2021) Vitamin D supplementation: upper limit for safety revisited? Aging Clin Exp Res. 33(1):19–24. https://doi.org/10.1007/s40520-020-01678-xCrossRefPubMed

62.

Fuggle NR, Cooper C, Harvey NC, Al-Daghri N, Brandi ML, Bruyere O, Cano A, Dennison EM, Diez-Perez A, Kaufman JM, Palacios S, Prieto-Alhambra D, Rozenberg S, Thomas T, Tremollieres F, Rizzoli R, Kanis JA, Reginster JY (2020) Assessment of cardiovascular safety of anti-osteoporosis drugs. Drugs 80(15):1537–1552. https://doi.org/10.1007/s40265-020-01364-2.PMID:32725307;PMCID:PMC7536167CrossRefPubMedPubMedCentral

63.

Curtis EM, Cooper C, Harvey NC (2021) Cardiovascular safety of calcium, magnesium and strontium: what does the evidence say? Aging Clin Exp Res 33(3):479–494. https://doi.org/10.1007/s40520-021-01799-xCrossRefPubMedPubMedCentral

64.

http://www.pnmedycznych.pl/wp-content/uploads/2016/10/pnm_2016_777-80.pdf.

65.

Gregson CL, Hardcastle SA, Cooper C, Tobias JH (2013) Friend or foe: high bone mineral density on routine bone density scanning, a review of causes and management. Rheumatology (Oxford). 52(6):968–85. https://doi.org/10.1093/rheumatology/ket007CrossRefPubMedPubMedCentral

66.

Kanis JA, Cooper C, Rizzoli R, Reginster JY, Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF) (2019) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 30(1):3–44. https://doi.org/10.1007/s00198-018-4704-5. Erratum in: Osteoporos Int. 2020;31(1):209. Erratum in: Osteoporos Int. 2020;31(4):801

67.

Meier C, Uebelhart B, Aubry-Rozier B, Birkhäuser M, Bischoff-Ferrari HA, Frey D, Kressig RW, Lamy O, Lippuner K, Stute P, Suhm N, Ferrari S (2017) Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the SVGO/ASCO. Swiss Med Wkly 147:w14484. https://doi.org/10.4414/smw.2017.14484CrossRefPubMed

68.

Camacho PM, Petak SM, Binkley N, Diab DL, Eldeiry LS, Farooki A, Harris ST, Hurley DL, Kelly J, Lewiecki EM, Pessah-Pollack R, McClung M, Wimalawansa SJ, Watts NB (2020) American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis-2020 update. Endocr Pract 26(Suppl 1):1–46. https://doi.org/10.4158/GL-2020-0524SUPPLCrossRefPubMed

69.

Diab DL, Watts NB (2013) Bisphosphonate drug holiday: who, when and how long. Ther Adv Musculoskelet Dis 5(3):107–111. https://doi.org/10.1177/1759720X13477714CrossRefPubMedPubMedCentral

70.

Bone HG, Hosking D, Devogelaer JP, Tucci JR, Emkey RD, Tonino RP, Rodriguez-Portales JA, Downs RW, Gupta J, Santora AC, Liberman UA (2004) Ten years’ experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med 350(12):1189–99. https://doi.org/10.1056/NEJMoa030897CrossRefPubMed

71.

Fink HA, MacDonald R, Forte ML, Rosebush CE, Ensrud KE, Schousboe JT, Nelson VA, Ullman K, Butler M, Olson CM, Taylor BC, Brasure M, Wilt TJ (2019) Long-term drug therapy and drug discontinuations and holidays for osteoporosis fracture prevention: a systematic review. Ann Intern Med 171(1):37–50. https://doi.org/10.7326/M19-0533CrossRefPubMed

72.

Kanis JA, Harvey NC, McCloskey E, Bruyère O, Veronese N, Lorentzon M, Cooper C, Rizzoli R, Adib G, Al-Daghri N, Campusano C, Chandran M, Dawson-Hughes B, Javaid K, Jiwa F, Johansson H, Lee JK, Liu E, Messina D, Mkinsi O, Pinto D, Prieto-Alhambra D, Saag K, Xia W, Zakraoui L, Reginster J (2020) Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures. Osteoporos Int 31(1):1–12. https://doi.org/10.1007/s00198-019-05176-3. Erratum in: Osteoporos Int. 2020;31(4):797–798

73.

Bone HG, Wagman RB, Brandi ML, Brown JP, Chapurlat R, Cummings SR et al (2017) 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension. Lancet Diabetes Endocrinol 5(7):513–523. https://doi.org/10.1016/S2213-8587(17)30138-9CrossRefPubMed

74.

Li N, Cornelissen D, Silverman S, Pinto D, Si L, Kremer I, Bours S, de Bot R, Boonen A, Evers S, van den Bergh J, Reginster JY, Hiligsmann M (2021) An updated systematic review of cost-effectiveness analyses of drugs for osteoporosis. Pharmacoeconomics. 39(2):181–209. https://doi.org/10.1007/s40273-020-00965-9CrossRefPubMed

75.

Lems WF, Raterman HG (2017) Critical issues and current challenges in osteoporosis and fracture prevention. An overview of unmet needs. Ther Adv Musculoskelet Dis 9(12):299–316. https://doi.org/10.1177/1759720X17732562CrossRefPubMedPubMedCentral

76.

Guggina P, Flahive J, Hooven FH, Watts NB, Siris ES, Silverman S, Roux C, Pfeilschifter J, Greenspan SL, Díez-Pérez A, Cooper C, Compston JE, Chapurlat R, Boonen S, Adachi JD, Anderson FA Jr, Gehlbach S, GLOW Investigators (2012) Characteristics associated with anti-osteoporosis medication use: data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) USA cohort. Bone 51(6):975–80. https://doi.org/10.1016/j.bone.2012.08.130CrossRefPubMedPubMedCentral

77.

Klop C, Gibson-Smith D, Elders PJ et al (2015) Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000–2010. Osteoporos Int 26(7):1919–1928. https://doi.org/10.1007/s00198-015-3098-xCrossRefPubMedPubMedCentral

78.

Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O'Ryan F; American Association of Oral and Maxillofacial Surgeons (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. J Oral Maxillofac Surg 72(10):1938–1956. https://doi.org/10.1016/j.joms.2014.04.031. Erratum in: J Oral Maxillofac Surg. 2015;73(7):1440. Erratum in: J Oral Maxillofac Surg. 2015;73(9):1879

79.

Wan JT, Sheeley DM, Somerman MJ, Lee JS (2020) Mitigating osteonecrosis of the jaw (ONJ) through preventive dental care and understanding of risk factors. Bone Res 11(8):14. https://doi.org/10.1038/s41413-020-0088-1CrossRef

80.

Rosen HN (2021) Risks of bisphosphonate therapy in patients with osteoporosis. UpToDate. Access date: Sepember, 22, 2021

81.

https://www.sheffield.ac.uk/NOGG%20Guideline%202017.pdf. Access date September 22, 2021

82.

Kossioni AE (2018) The association of poor oral health parameters with malnutrition in older adults: a review considering the potential implications for cognitive impairment. Nutrients 10(11):1709. https://doi.org/10.3390/nu10111709CrossRefPubMedCentral

83.

Yoshida M, Suzuki R, Kikutani T (2013) Nutrition and oral status in elderly people. Jpn Dent Sci Rev 50:9–14. https://doi.org/10.1016/j.jdsr.2013.09.001CrossRef

84.

https://www.aegisdentalnetwork.com/cced/2020/05/teeth-in-geriatric-patients-to-restore-or-extract. Access date September 23, 2021

85.

Symonds C, Kline G (2018) Warning of an increased risk of vertebral fracture after stopping denosumab. CMAJ 190(16):E485–E486. https://doi.org/10.1503/cmaj.180115CrossRefPubMedPubMedCentral

86.

Denosumab: drug information Lexicomp, UpToDate. 2021. Access date: March 2021

87.

Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D (2019) Pharmacological management of osteoporosis in postmenopausal women: an endocrine society* clinical practice guideline. J Clin Endocrinol Metab 104(5):1595–1622. https://doi.org/10.1210/jc.2019-00221CrossRefPubMed

88.

Liberman D, Cheung A (2015) A practical approach to osteoporosis management in the geriatric population. Can Geriatr J 18(1):29–34. https://doi.org/10.5770/cgj.18.129CrossRefPubMedPubMedCentral

89.

Sleeman A, Clements JN (2019) Abaloparatide: a new pharmacological option for osteoporosis. Am J Health Syst Pharm 76(3):130–135. https://doi.org/10.1093/ajhp/zxy022CrossRefPubMed

90.

Reginster J, Bianic F, Campbell R, Martin M, Williams SA, Fitzpatrick LA (2019) Abaloparatide for risk reduction of nonvertebral and vertebral fractures in postmenopausal women with osteoporosis: a network meta-analysis. Osteoporos Int 30(7):1465–1473. https://doi.org/10.1007/s00198-019-04947-2CrossRefPubMedCentral

91.

Paik J, Scott LJ (2020) Romosozumab: a review in postmenopausal osteoporosis. Drugs Aging 37(11):845-855. https://doi.org/10.1007/s40266-020-00793-8. Erratum in: Drugs Aging. 2020

92.

Rauner M, Taipaleenmäki H, Tsourdi E, Winter EM (2021) Osteoporosis treatment with anti-sclerostin antibodies-mechanisms of action and clinical application. J Clin Med 10(4):787. https://doi.org/10.3390/jcm10040787CrossRefPubMedPubMedCentral

93.

Wu CH, Kao IJ, Hung WC, Lin SC, Liu HC, Hsieh MH, Bagga S, Achra M, Cheng TT, Yang RS (2018) Economic impact and cost-effectiveness of fracture liaison services: a systematic review of the literature. Osteoporos Int 29(6):1227–1242. https://doi.org/10.1007/s00198-018-4411-2CrossRefPubMed

94.

Fuggle NR, Kassim Javaid M, Fujita M, Halbout P, Dawson-Hughes B, Rizzoli R, Reginster JY, Kanis JA, Cooper C (2020) Fracture risk assessment and How to implement a fracture liaison service. In: Falaschi P, Marsh D, editors. Orthogeriatrics: the management of older patients with fragility fractures [Internet]. Springer, Cham; 2021. Chapter 14

95.

https://www.capturethefracture.org/index.php/map-of-best-practice. Access date September 22, 2021

96.

Yu M, Downey C, Torralba KD (2020) The fracture liaison service to close the osteoporosis care gap: a leadership educational model for undergraduate and postgraduate trainees. Clin Rheumatol 39:619–626. https://doi.org/10.1007/s10067-019-04796-8CrossRefPubMed

97.

Walters S, Khan T, Ong T, Sahota O (2017) Fracture liaison services: improving outcomes for patients with osteoporosis. Clin Interv Aging 12:117–127. Published 2017. https://doi.org/10.2147/CIA.S85551

98.

Bahat G, Catikkas NM, Karan MA, Reginster JY (2021) Orthogeriatrics: a vital requirement for improving fragility fracture patient care internationally with particular reference to Turkey. Arch Osteoporos 16(1):103. https://doi.org/10.1007/s11657-021-00967-wCrossRefPubMed

99.

Soulis G, Kotovskaya Y, Bahat G, Duque S, Gouiaa R, Ekdahl AW, Sieber C, Petrovic M, Benetos A (2021) Geriatric care in European countries where geriatric medicine is still emerging. Eur Geriatr Med. 12(1):205–211. https://doi.org/10.1007/s41999-020-00419-7CrossRefPubMed

Title: The current situation in the approach to osteoporosis in older adults in Turkey: areas in need of improvement with a model for other populations
Authors: Gulistan Bahat
Nezahat Muge Catikkas
Dilek Gogas Yavuz
Pinar Borman
Rengin Guzel
Jean Yves Reginster
Publication date: 01-12-2021
Publisher: Springer London
Keywords: Osteoporosis
Osteoporosis
Denosumab
Denosumab
Published in: Archives of Osteoporosis / Issue 1/2021
Print ISSN: 1862-3522
Electronic ISSN: 1862-3514
DOI: https://doi.org/10.1007/s11657-021-01038-w

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

The current situation in the approach to osteoporosis in older adults in Turkey: areas in need of improvement with a model for other populations

Abstract

Purpose

Methods

Results

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2021

Insufficient persistence to pharmacotherapy in Japanese patients with osteoporosis: an analysis of the National Database of Health Insurance Claims and Specific Health Checkups in Japan

Dysmobility syndrome: a case-series study describing a musculoskeletal syndrome in postmenopausal Mexican women

Performance of HR-pQCT, DXA, and FRAX in the discrimination of asymptomatic vertebral fracture in postmenopausal Chinese women

Sleep pattern and bone mineral density: a cross-sectional study of National Health and Nutrition Examination Survey (NHANES) 2017–2018

Diagnosis and management of X-linked hypophosphatemia in children and adolescent in the Gulf Cooperation Council countries

Do sandwich vertebral bodies increase the risk of post-augmentation fractures? A retrospective cohort study